Efficacy and Safety of Shouhui Tongbian Capsule in the Treatment of Functional Constipation after Marketing: a Single-Center, Open Clinical Study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043977

Enrollment

Unknown

Registered

2021-03-06

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation

Interventions

Functional constipation group:Oral Shouhuitongbiao capsule, 2 pills at a time, 3 times a day, a course of 14 days

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Willing to sign the informed consent; 2. Male or female aged 18-70 years; 3. Meet the diagnostic criteria of functional constipation; 4. Willing and able to comply with the test protocol; 5. Willing to follow the instructions of researchers.

Exclusion criteria

Exclusion criteria: 1. Constipation caused by organic lesions; 2. Patients who have used drugs to treat functional constipation within the last 2 weeks; 3. Patients with severe liver dysfunction; 4. Patients with severe renal insufficiency; 5. Previous history of liver injury caused by Polygonum multiflorum or preparations containing Polygonum multiflorum multiflorum; 6. Pregnant or preparing-for-pregnancy women, nursing women; 7. Allergic physique or allergic to this drug; 8. The researcher judged that the subjects had poor compliance and could not complete the study according to the program requirements.

Design outcomes

Primary

Measure	Time frame
Wexner score;	—

Countries

China

Contacts

Public ContactHong Zhao

Songyuan Jilin Oilfield Hospital

498067498@qq.com+86 13843889904

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026